Healthcare >> CEO Interviews >> March 15, 1999
DR. STEVEN GILLIS is President & CEO of Corixa Corporation. Education:
1971-75 B.A. (Cum Laude) Highest Honors in Biology William's College
Williamstown, Massachusetts; 1975-78 Ph.D., Biological Sciences,
Specialization: Cellular and Tumor Immunology, Dartmouth College
Hanover, New Hampshire. Honors: 1975 Phi Beta Kappa; 1975 Sigma Xi,
Associate Member; 1976 Conant-Harrington Prize for Outstanding Research
in Biology; 1982 New York Academy of Science; 1983 International
Immunopharmacology Award. Positions Held: 1994 President, Chief
Executive Officer Corixa Corporation, Seattle, WA; 1990-94 President,
CEO, Immunex Research and Development Corporation, Seattle, WA; 1990-97
Adjunct Professor, University of Washington, Department of Immunology,
Seattle, WA; 1988-90 President, Chief Operating Officer, Immunex
Research and Development Corporation, Seattle, WA; 1982- Executive Vice
President, Director of Research and Development, Immunex Corporation;
1982-90 Adjunct Associate Professor, University of Washington,
Department of Microbiology and Immunology, Seattle, WA; 1982- 90
Affiliate Investigator, Basic Immunology Program, Fred Hutchinson Cancer
Research Center, Seattle, WA; 1980-83 Assistant Professor, Department of
Microbiology and Immunology, University of Washington, Seattle, WA;
1980-82 Assistant Member, Basic Immunology Program, Fred Hutchinson
Cancer Research Center, Seattle, WA; 1979-80 Associate Researcher,
Memorial Sloan-Kettering Cancer Center, Laboratory of Development
Hematopoiesis, New York, NY; 1978-79 Research Associate, Hematology
Research, Dartmouth Medical School, Hanover, NH; 1977-78 Lecturer in
Biology, Department of Biological Sciences, Dartmouth College, Hanover,
NH; 1976-78 Research Fellow, Department of Biological Sciences, Norris
Cotton Cancer Center, Hanover, NH and 1975-76 Teaching Fellow,
Department of Biological Sciences, Dartmouth College, Hanover, NH. Profile
TWST: Could you begin by giving us a background summary on the company,enough information to put us into context as what you see as your
business and what you see as your company today?
Dr.